APO Research
Talk to an analyst

APO RESEARCH · REPORT

Candida Antarctica Lipase B

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Candida Antarctica Lipase B Market Outlook and Growth Opportunities 2026

13 August 2026191 pages

Choose your research edition.

Industry ResearchCandida Antarctica Lipase B Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Candida Antarctica Lipase B Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Candida Antarctica Lipase B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Candida Antarctica Lipase B Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Candida Antarctica Lipase B Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Candida Antarctica Lipase B market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Candida Antarctica Lipase B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Candida Antarctica Lipase B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Candida Antarctica Lipase B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Candida Antarctica Lipase B market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Candida Antarctica Lipase B market include KDN Biotech, SyncoZymes, Biosynth, Merck, Aladdin Scientific, Creative Enzymes, Creative BioMart, MedChemExpress and ProteoGenix, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Candida Antarctica Lipase B market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Candida Antarctica Lipase B and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Candida Antarctica Lipase B sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Candida Antarctica Lipase B market size, projected growth trends, production technologies, key applications, and end-use industries.

Candida Antarctica Lipase B Segment by Company

KDN Biotech

SyncoZymes

Biosynth

Merck

Aladdin Scientific

Creative Enzymes

Creative BioMart

MedChemExpress

ProteoGenix

Novonesis

Fermenta Biotech

Advanced Enzymes

Candida Antarctica Lipase B Segment by Type

Free Liquid Formulation

Free Powder Preparation

Immobilized Granular Biocatalyst

Immobilized Microcarrier Biocatalyst

Whole-cell Biocatalyst

Candida Antarctica Lipase B Segment by Application

Pharmaceutical Intermediates and Chiral Resolution

Specialty Fats and Omega-3 Oils

Flavor, Fragrance and Cosmetic Esters

Bio-based Polyester Synthesis

Biodiesel and Oleochemical Processing

Research and Enzyme Engineering

Candida Antarctica Lipase B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Candida Antarctica Lipase B status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Candida Antarctica Lipase B market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Candida Antarctica Lipase B significant trends, drivers, influence factors in global and regions.

6. To analyze Candida Antarctica Lipase B competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Candida Antarctica Lipase B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Candida Antarctica Lipase B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Candida Antarctica Lipase B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Candida Antarctica Lipase B market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Candida Antarctica Lipase B industry.

Chapter 3: Detailed analysis of Candida Antarctica Lipase B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Candida Antarctica Lipase B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Candida Antarctica Lipase B in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Candida Antarctica Lipase B Industry Trends Table 2. Candida Antarctica Lipase B Industry Drivers Table 3. Candida Antarctica Lipase B Industry Opportunities and Challenges Table 4. Candida Antarctica Lipase B Industry Restraints Table 5. Global Candida Antarctica Lipase B Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Candida Antarctica Lipase B Revenue Share by Company (2021-2026) Table 7. Global Candida Antarctica Lipase B Sales Volume by Company (t) & (2021-2026) Table 8. Global Candida Antarctica Lipase B Sales Volume Share by Company (2021-2026) Table 9. Global Candida Antarctica Lipase B Average Price (USD/t) of Company (2021-2026) Table 10. Global Candida Antarctica Lipase B Company Ranking, (2024-2026) & (USD Million) Table 11. Global Candida Antarctica Lipase B Key Company Manufacturing Base & Headquarters Table 12. Global Candida Antarctica Lipase B Company, Product Type & Application Table 13. Global Candida Antarctica Lipase B Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Candida Antarctica Lipase B by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Free Liquid Formulation Table 18. Significant Companies of Free Powder Preparation Table 19. Significant Companies of Immobilized Granular Biocatalyst Table 20. Significant Companies of Immobilized Microcarrier Biocatalyst Table 21. Significant Companies of Whole-cell Biocatalyst Table 22. Global Candida Antarctica Lipase B Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 23. Global Candida Antarctica Lipase B Sales Volume by Type (2021-2026) & (t) Table 24. Global Candida Antarctica Lipase B Sales Volume by Type (2027-2032) & (t) Table 25. Global Candida Antarctica Lipase B Sales Volume Share by Type (2021-2026) Table 26. Global Candida Antarctica Lipase B Sales Volume Share by Type (2027-2032) Table 27. Global Candida Antarctica Lipase B Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Candida Antarctica Lipase B Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Candida Antarctica Lipase B Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Candida Antarctica Lipase B Sales Value Share by Type (2021-2026) Table 31. Global Candida Antarctica Lipase B Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Pharmaceutical Intermediates and Chiral Resolution Table 33. Significant Companies of Specialty Fats and Omega-3 Oils Table 34. Significant Companies of Flavor, Fragrance and Cosmetic Esters Table 35. Significant Companies of Bio-based Polyester Synthesis Table 36. Significant Companies of Biodiesel and Oleochemical Processing Table 37. Significant Companies of Research and Enzyme Engineering Table 38. Global Candida Antarctica Lipase B Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 39. Global Candida Antarctica Lipase B Sales Volume by Application (2021-2026) & (t) Table 40. Global Candida Antarctica Lipase B Sales Volume by Application (2027-2032) & (t) Table 41. Global Candida Antarctica Lipase B Sales Volume Share by Application (2021-2026) Table 42. Global Candida Antarctica Lipase B Sales Volume Share by Application (2027-2032) Table 43. Global Candida Antarctica Lipase B Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 44. Global Candida Antarctica Lipase B Sales Value by Application (2021-2026) & (US$ Million) Table 45. Global Candida Antarctica Lipase B Sales Value by Application (2027-2032) & (US$ Million) Table 46. Global Candida Antarctica Lipase B Sales Value Share by Application (2021-2026) Table 47. Global Candida Antarctica Lipase B Sales Value Share by Application (2027-2032) Table 48. Global Candida Antarctica Lipase B Sales by Region: 2021 VS 2025 VS 2032 (t) Table 49. Global Candida Antarctica Lipase B Sales by Region (2021-2026) & (t) Table 50. Global Candida Antarctica Lipase B Sales Market Share by Region (2021-2026) Table 51. Global Candida Antarctica Lipase B Sales by Region (2027-2032) & (t) Table 52. Global Candida Antarctica Lipase B Sales Market Share by Region (2027-2032) Table 53. Global Candida Antarctica Lipase B Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 54. Global Candida Antarctica Lipase B Sales Value by Region (2021-2026) & (US$ Million) Table 55. Global Candida Antarctica Lipase B Sales Value Share by Region (2021-2026) Table 56. Global Candida Antarctica Lipase B Sales Value by Region (2027-2032) & (US$ Million) Table 57. Global Candida Antarctica Lipase B Sales Value Share by Region (2027-2032) Table 58. Global Candida Antarctica Lipase B Market Average Price (USD/t) by Region (2021-2026) Table 59. Global Candida Antarctica Lipase B Market Average Price (USD/t) by Region (2027-2032) Table 60. Global Candida Antarctica Lipase B Sales by Country: 2021 VS 2025 VS 2032 (t) Table 61. Global Candida Antarctica Lipase B Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Candida Antarctica Lipase B Sales by Country (2021-2026) & (t) Table 63. Global Candida Antarctica Lipase B Sales Market Share by Country (2021-2026) Table 64. Global Candida Antarctica Lipase B Sales by Country (2027-2032) & (t) Table 65. Global Candida Antarctica Lipase B Sales Market Share by Country (2027-2032) Table 66. Global Candida Antarctica Lipase B Sales Value by Country (2021-2026) & (US$ Million) Table 67. Global Candida Antarctica Lipase B Sales Value Market Share by Country (2021-2026) Table 68. Global Candida Antarctica Lipase B Sales Value by Country (2027-2032) & (US$ Million) Table 69. Global Candida Antarctica Lipase B Sales Value Market Share by Country (2027-2032) Table 70. KDN Biotech Company Information Table 71. KDN Biotech Business Overview Table 72. KDN Biotech Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. KDN Biotech Candida Antarctica Lipase B Product Portfolio Table 74. KDN Biotech Recent Development Table 75. SyncoZymes Company Information Table 76. SyncoZymes Business Overview Table 77. SyncoZymes Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. SyncoZymes Candida Antarctica Lipase B Product Portfolio Table 79. SyncoZymes Recent Development Table 80. Biosynth Company Information Table 81. Biosynth Business Overview Table 82. Biosynth Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. Biosynth Candida Antarctica Lipase B Product Portfolio Table 84. Biosynth Recent Development Table 85. Merck Company Information Table 86. Merck Business Overview Table 87. Merck Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Merck Candida Antarctica Lipase B Product Portfolio Table 89. Merck Recent Development Table 90. Aladdin Scientific Company Information Table 91. Aladdin Scientific Business Overview Table 92. Aladdin Scientific Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Aladdin Scientific Candida Antarctica Lipase B Product Portfolio Table 94. Aladdin Scientific Recent Development Table 95. Creative Enzymes Company Information Table 96. Creative Enzymes Business Overview Table 97. Creative Enzymes Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. Creative Enzymes Candida Antarctica Lipase B Product Portfolio Table 99. Creative Enzymes Recent Development Table 100. Creative BioMart Company Information Table 101. Creative BioMart Business Overview Table 102. Creative BioMart Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. Creative BioMart Candida Antarctica Lipase B Product Portfolio Table 104. Creative BioMart Recent Development Table 105. MedChemExpress Company Information Table 106. MedChemExpress Business Overview Table 107. MedChemExpress Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. MedChemExpress Candida Antarctica Lipase B Product Portfolio Table 109. MedChemExpress Recent Development Table 110. ProteoGenix Company Information Table 111. ProteoGenix Business Overview Table 112. ProteoGenix Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. ProteoGenix Candida Antarctica Lipase B Product Portfolio Table 114. ProteoGenix Recent Development Table 115. Novonesis Company Information Table 116. Novonesis Business Overview Table 117. Novonesis Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 118. Novonesis Candida Antarctica Lipase B Product Portfolio Table 119. Novonesis Recent Development Table 120. Fermenta Biotech Company Information Table 121. Fermenta Biotech Business Overview Table 122. Fermenta Biotech Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 123. Fermenta Biotech Candida Antarctica Lipase B Product Portfolio Table 124. Fermenta Biotech Recent Development Table 125. Advanced Enzymes Company Information Table 126. Advanced Enzymes Business Overview Table 127. Advanced Enzymes Candida Antarctica Lipase B Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 128. Advanced Enzymes Candida Antarctica Lipase B Product Portfolio Table 129. Advanced Enzymes Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Candida Antarctica Lipase B Distributors List Table 133. Candida Antarctica Lipase B Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Candida Antarctica Lipase B Product Image Figure 2. Global Candida Antarctica Lipase B Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Candida Antarctica Lipase B Sales Value (2021-2032) & (US$ Million) Figure 4. Global Candida Antarctica Lipase B Sales (2021-2032) & (t) Figure 5. Global Candida Antarctica Lipase B Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Candida Antarctica Lipase B Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Free Liquid Formulation Image Figure 10. Free Powder Preparation Image Figure 11. Immobilized Granular Biocatalyst Image Figure 12. Immobilized Microcarrier Biocatalyst Image Figure 13. Whole-cell Biocatalyst Image Figure 14. Global Candida Antarctica Lipase B Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 15. Global Candida Antarctica Lipase B Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Candida Antarctica Lipase B Sales Volume Share by Type (2021-2032) Figure 17. Global Candida Antarctica Lipase B Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Candida Antarctica Lipase B Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Candida Antarctica Lipase B Sales Value Share by Type (2021-2032) Figure 20. Pharmaceutical Intermediates and Chiral Resolution Image Figure 21. Specialty Fats and Omega-3 Oils Image Figure 22. Flavor, Fragrance and Cosmetic Esters Image Figure 23. Bio-based Polyester Synthesis Image Figure 24. Biodiesel and Oleochemical Processing Image Figure 25. Research and Enzyme Engineering Image Figure 26. Global Candida Antarctica Lipase B Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 27. Global Candida Antarctica Lipase B Sales Volume Share 2021 VS 2025 VS 2032 Figure 28. Global Candida Antarctica Lipase B Sales Volume Share by Application (2021-2032) Figure 29. Global Candida Antarctica Lipase B Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Candida Antarctica Lipase B Sales Value Share 2021 VS 2025 VS 2032 Figure 31. Global Candida Antarctica Lipase B Sales Value Share by Application (2021-2032) Figure 32. Global Candida Antarctica Lipase B Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 33. Global Candida Antarctica Lipase B Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. Global Candida Antarctica Lipase B Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. Global Candida Antarctica Lipase B Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 36. North America Candida Antarctica Lipase B Sales Value (2021-2032) & (US$ Million) Figure 37. North America Candida Antarctica Lipase B Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Europe Candida Antarctica Lipase B Sales Value (2021-2032) & (US$ Million) Figure 39. Europe Candida Antarctica Lipase B Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Asia-Pacific Candida Antarctica Lipase B Sales Value (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Candida Antarctica Lipase B Sales Value Share by Country (%), 2025 VS 2032 Figure 42. South America Candida Antarctica Lipase B Sales Value (2021-2032) & (US$ Million) Figure 43. South America Candida Antarctica Lipase B Sales Value Share by Country (%), 2025 VS 2032 Figure 44. Middle East & Africa Candida Antarctica Lipase B Sales Value (2021-2032) & (US$ Million) Figure 45. Middle East & Africa Candida Antarctica Lipase B Sales Value Share by Country (%), 2025 VS 2032 Figure 46. USA Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. USA Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. USA Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Canada Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Canada Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Canada Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Mexico Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Mexico Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Mexico Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Germany Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Germany Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Germany Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. France Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. France Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. France Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. U.K. Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. U.K. Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. U.K. Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Italy Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Italy Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Italy Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Spain Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Spain Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Spain Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Russia Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Russia Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Russia Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Netherlands Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Netherlands Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Netherlands Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Nordic Countries Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Nordic Countries Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Nordic Countries Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. China Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. China Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. China Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Japan Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Japan Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Japan Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. South Korea Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. South Korea Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. South Korea Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. India Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. India Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. India Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Australia Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Australia Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Australia Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Southeast Asia Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Southeast Asia Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Southeast Asia Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Brazil Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Brazil Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Brazil Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Argentina Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Argentina Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Argentina Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Chile Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Chile Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Chile Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Colombia Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Colombia Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Colombia Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Peru Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Peru Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Peru Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Saudi Arabia Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Israel Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Israel Arabia Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Israel Arabia Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. UAE Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. UAE Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. UAE Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Turkey Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Turkey Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Turkey Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Iran Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Iran Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Iran Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Egypt Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 128. Egypt Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 129. Egypt Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 130. Candida Antarctica Lipase B Value Chain Figure 131. Manufacturing Cost Structure Figure 132. Candida Antarctica Lipase B Sales Mode & Process Figure 133. Direct Comparison with Distribution Share Figure 134. Distributors Profiles Figure 135. Years Considered Figure 136. Research Process Figure 137. Key Executives Interviewed

Scope & coverage.

Types
  • Free Liquid Formulation
  • Free Powder Preparation
  • Immobilized Granular Biocatalyst
  • Immobilized Microcarrier Biocatalyst
  • Whole-cell Biocatalyst
Applications
  • Pharmaceutical Intermediates and Chiral Resolution
  • Specialty Fats and Omega-3 Oils
  • Flavor, Fragrance and Cosmetic Esters
  • Bio-based Polyester Synthesis
  • Biodiesel and Oleochemical Processing
  • Research and Enzyme Engineering
Companies covered
  • KDN Biotech
  • SyncoZymes
  • Biosynth
  • Merck
  • Aladdin Scientific
  • Creative Enzymes
  • Creative BioMart
  • MedChemExpress
  • ProteoGenix
  • Novonesis
  • Fermenta Biotech
  • Advanced Enzymes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Candida Antarctica Lipase B Sales Value (2021-2032)
  4. 1.2.2 Global Candida Antarctica Lipase B Sales Volume (2021-2032)
  5. 1.2.3 Global Candida Antarctica Lipase B Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Candida Antarctica Lipase B Market Dynamics
  1. 2.1 Candida Antarctica Lipase B Industry Trends
  2. 2.2 Candida Antarctica Lipase B Industry Drivers
  3. 2.3 Candida Antarctica Lipase B Industry Opportunities and Challenges
  4. 2.4 Candida Antarctica Lipase B Industry Restraints
3 Candida Antarctica Lipase B Market by Company
  1. 3.1 Global Candida Antarctica Lipase B Company Revenue Ranking in 2025
  2. 3.2 Global Candida Antarctica Lipase B Revenue by Company (2021-2026)
  3. 3.3 Global Candida Antarctica Lipase B Sales Volume by Company (2021-2026)
  4. 3.4 Global Candida Antarctica Lipase B Average Price by Company (2021-2026)
  5. 3.5 Global Candida Antarctica Lipase B Company Ranking (2024-2026)
  6. 3.6 Global Candida Antarctica Lipase B Company Manufacturing Base and Headquarters
  7. 3.7 Global Candida Antarctica Lipase B Company Product Type and Application
  8. 3.8 Global Candida Antarctica Lipase B Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Candida Antarctica Lipase B Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Candida Antarctica Lipase B Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Candida Antarctica Lipase B Market by Type
  1. 4.1 Candida Antarctica Lipase B Type Introduction
  2. 4.1.1 Free Liquid Formulation
  3. 4.1.2 Free Powder Preparation
  4. 4.1.3 Immobilized Granular Biocatalyst
  5. 4.1.4 Immobilized Microcarrier Biocatalyst
  6. 4.1.5 Whole-cell Biocatalyst
  7. 4.2 Global Candida Antarctica Lipase B Sales Volume by Type
  8. 4.2.1 Global Candida Antarctica Lipase B Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Candida Antarctica Lipase B Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Candida Antarctica Lipase B Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Candida Antarctica Lipase B Sales Value by Type
  12. 4.3.1 Global Candida Antarctica Lipase B Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Candida Antarctica Lipase B Sales Value by Type (2021-2032)
  14. 4.3.3 Global Candida Antarctica Lipase B Sales Value Share by Type (2021-2032)
5 Candida Antarctica Lipase B Market by Application
  1. 5.1 Candida Antarctica Lipase B Application Introduction
  2. 5.1.1 Pharmaceutical Intermediates and Chiral Resolution
  3. 5.1.2 Specialty Fats and Omega-3 Oils
  4. 5.1.3 Flavor, Fragrance and Cosmetic Esters
  5. 5.1.4 Bio-based Polyester Synthesis
  6. 5.1.5 Biodiesel and Oleochemical Processing
  7. 5.1.6 Research and Enzyme Engineering
  8. 5.2 Global Candida Antarctica Lipase B Sales Volume by Application
  9. 5.2.1 Global Candida Antarctica Lipase B Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Candida Antarctica Lipase B Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Candida Antarctica Lipase B Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Candida Antarctica Lipase B Sales Value by Application
  13. 5.3.1 Global Candida Antarctica Lipase B Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Candida Antarctica Lipase B Sales Value by Application (2021-2032)
  15. 5.3.3 Global Candida Antarctica Lipase B Sales Value Share by Application (2021-2032)
6 Candida Antarctica Lipase B Regional Sales and Value Analysis
  1. 6.1 Global Candida Antarctica Lipase B Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Candida Antarctica Lipase B Sales by Region (2021-2032)
  3. 6.2.1 Global Candida Antarctica Lipase B Sales by Region: 2021-2026
  4. 6.2.2 Global Candida Antarctica Lipase B Sales by Region (2027-2032)
  5. 6.3 Global Candida Antarctica Lipase B Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Candida Antarctica Lipase B Sales Value by Region (2021-2032)
  7. 6.4.1 Global Candida Antarctica Lipase B Sales Value by Region: 2021-2026
  8. 6.4.2 Global Candida Antarctica Lipase B Sales Value by Region (2027-2032)
  9. 6.5 Global Candida Antarctica Lipase B Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Candida Antarctica Lipase B Sales Value (2021-2032)
  12. 6.6.2 North America Candida Antarctica Lipase B Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Candida Antarctica Lipase B Sales Value (2021-2032)
  15. 6.7.2 Europe Candida Antarctica Lipase B Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Candida Antarctica Lipase B Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Candida Antarctica Lipase B Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Candida Antarctica Lipase B Sales Value (2021-2032)
  21. 6.9.2 South America Candida Antarctica Lipase B Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Candida Antarctica Lipase B Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Candida Antarctica Lipase B Sales Value Share by Country, 2025 VS 2032
7 Candida Antarctica Lipase B Country-level Sales and Value Analysis
  1. 7.1 Global Candida Antarctica Lipase B Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Candida Antarctica Lipase B Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Candida Antarctica Lipase B Sales by Country (2021-2032)
  4. 7.3.1 Global Candida Antarctica Lipase B Sales by Country (2021-2026)
  5. 7.3.2 Global Candida Antarctica Lipase B Sales by Country (2027-2032)
  6. 7.4 Global Candida Antarctica Lipase B Sales Value by Country (2021-2032)
  7. 7.4.1 Global Candida Antarctica Lipase B Sales Value by Country (2021-2026)
  8. 7.4.2 Global Candida Antarctica Lipase B Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Candida Antarctica Lipase B Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Candida Antarctica Lipase B Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Candida Antarctica Lipase B Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 KDN Biotech
  2. 8.1.1 KDN Biotech Company Information
  3. 8.1.2 KDN Biotech Business Overview
  4. 8.1.3 KDN Biotech Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 KDN Biotech Candida Antarctica Lipase B Product Portfolio
  6. 8.1.5 KDN Biotech Recent Developments
  7. 8.2 SyncoZymes
  8. 8.2.1 SyncoZymes Company Information
  9. 8.2.2 SyncoZymes Business Overview
  10. 8.2.3 SyncoZymes Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 SyncoZymes Candida Antarctica Lipase B Product Portfolio
  12. 8.2.5 SyncoZymes Recent Developments
  13. 8.3 Biosynth
  14. 8.3.1 Biosynth Company Information
  15. 8.3.2 Biosynth Business Overview
  16. 8.3.3 Biosynth Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Biosynth Candida Antarctica Lipase B Product Portfolio
  18. 8.3.5 Biosynth Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Candida Antarctica Lipase B Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Aladdin Scientific
  26. 8.5.1 Aladdin Scientific Company Information
  27. 8.5.2 Aladdin Scientific Business Overview
  28. 8.5.3 Aladdin Scientific Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Aladdin Scientific Candida Antarctica Lipase B Product Portfolio
  30. 8.5.5 Aladdin Scientific Recent Developments
  31. 8.6 Creative Enzymes
  32. 8.6.1 Creative Enzymes Company Information
  33. 8.6.2 Creative Enzymes Business Overview
  34. 8.6.3 Creative Enzymes Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Creative Enzymes Candida Antarctica Lipase B Product Portfolio
  36. 8.6.5 Creative Enzymes Recent Developments
  37. 8.7 Creative BioMart
  38. 8.7.1 Creative BioMart Company Information
  39. 8.7.2 Creative BioMart Business Overview
  40. 8.7.3 Creative BioMart Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Creative BioMart Candida Antarctica Lipase B Product Portfolio
  42. 8.7.5 Creative BioMart Recent Developments
  43. 8.8 MedChemExpress
  44. 8.8.1 MedChemExpress Company Information
  45. 8.8.2 MedChemExpress Business Overview
  46. 8.8.3 MedChemExpress Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MedChemExpress Candida Antarctica Lipase B Product Portfolio
  48. 8.8.5 MedChemExpress Recent Developments
  49. 8.9 ProteoGenix
  50. 8.9.1 ProteoGenix Company Information
  51. 8.9.2 ProteoGenix Business Overview
  52. 8.9.3 ProteoGenix Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 ProteoGenix Candida Antarctica Lipase B Product Portfolio
  54. 8.9.5 ProteoGenix Recent Developments
  55. 8.10 Novonesis
  56. 8.10.1 Novonesis Company Information
  57. 8.10.2 Novonesis Business Overview
  58. 8.10.3 Novonesis Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novonesis Candida Antarctica Lipase B Product Portfolio
  60. 8.10.5 Novonesis Recent Developments
  61. 8.11 Fermenta Biotech
  62. 8.11.1 Fermenta Biotech Company Information
  63. 8.11.2 Fermenta Biotech Business Overview
  64. 8.11.3 Fermenta Biotech Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Fermenta Biotech Candida Antarctica Lipase B Product Portfolio
  66. 8.11.5 Fermenta Biotech Recent Developments
  67. 8.12 Advanced Enzymes
  68. 8.12.1 Advanced Enzymes Company Information
  69. 8.12.2 Advanced Enzymes Business Overview
  70. 8.12.3 Advanced Enzymes Candida Antarctica Lipase B Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Advanced Enzymes Candida Antarctica Lipase B Product Portfolio
  72. 8.12.5 Advanced Enzymes Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Candida Antarctica Lipase B Value Chain Analysis
  2. 9.1.1 Candida Antarctica Lipase B Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Candida Antarctica Lipase B Sales Mode & Process
  6. 9.2 Candida Antarctica Lipase B Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Candida Antarctica Lipase B Distributors
  9. 9.2.3 Candida Antarctica Lipase B Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst